10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2020 | ||
Consolidated Balance Sheets | ||
Period Ending Jan 3, 2021 10-K (Filed: Feb 22, 2021) | ||
| (In Millions, except shares in Thousands) | ||
| As of | As of | |
| Jan 3, 2021 | Dec 29, 2019 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 13,985 | 17,305 |
| Marketable securities (Notes 1 and 2) | 11,200 | 1,982 |
| Accounts receivable trade, less allowances for doubtful accounts $293 (2019, $226) | 13,576 | 14,481 |
| Inventories (Notes 1 and 3) | 9,344 | 9,020 |
| Prepaid expenses and other receivables | 3,132 | 2,392 |
| Assets held for sale (Note 18) | 0 | 94 |
| Total current assets | 51,237 | 45,274 |
| Property, plant and equipment, net (Notes 1 and 4) | 18,766 | 17,658 |
| Intangible assets, net (Notes 1 and 5) | 53,402 | 47,643 |
| Goodwill (Notes 1 and 5) | 36,393 | 33,639 |
| Deferred taxes on income (Note 8) | 8,534 | 7,819 |
| Other assets | 6,562 | 5,695 |
| Total assets | 174,894 | 157,728 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Loans and notes payable (Note 7) | 2,631 | 1,202 |
| Accounts payable | 9,505 | 8,544 |
| Accrued liabilities | 13,968 | 9,715 |
| Accrued rebates, returns and promotions | 11,513 | 10,883 |
| Accrued compensation and employee related obligations | 3,484 | 3,354 |
| Accrued taxes on income (Note 8) | 1,392 | 2,266 |
| Total current liabilities | 42,493 | 35,964 |
| Long-term debt (Note 7) | 32,635 | 26,494 |
| Deferred taxes on income (Note 8) | 7,214 | 5,958 |
| Employee related obligations (Notes 9 and 10) | 10,771 | 10,663 |
| Long-term taxes payable (Note 1) | 6,559 | 7,444 |
| Other liabilities | 11,944 | 11,734 |
| Total liabilities | 111,616 | 98,257 |
| Shareholders' equity: | ||
| Preferred stock without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (loss) (Note 13) | (15,242) | (15,891) |
| Retained earnings | 113,890 | 110,659 |
| Stockholders' Equity before Treasury Stock | 101,768 | 97,888 |
| Less: common stock held in treasury, at cost (Note 12) (487,331,000 shares and 487,336,000 shares) | 38,490 | 38,417 |
| Total shareholders equity | 63,278 | 59,471 |
| Total liabilities and shareholders equity | 174,894 | 157,728 |
| Preferred stock, shares authorized (in shares) | 2,000 | 2,000 |
| Common Stock, Par or Stated Value Per Share | 1.0000 | 1.0000 |
| Common Stock, Shares Authorized | 4,320,000 | 4,320,000 |
| Common Stock, Shares, Issued | 3,119,843 | 3,119,843 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |